Unlike earlier studies that primarily focused on the relationship between gut microbiota and prediabetes, this study explored a novel approach by assessing whether the effects of administering or transplanting gut microbiota from healthy, lean individuals into participants with obesity and metabolic syndrome could enhance insulin sensitivity. The gene discussed is INS; the disease is obesity due to melanocortin 4 receptor deficiency.